Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Plos One
|
May 23, 2014
Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models
Mohamed R Akl, Nehad M Ayoub, Mohamed M Mohyeldin, et al.
Marine Drugs
|
January 13, 2015
Araguspongine C induces autophagic death in breast cancer cells through suppression of c-Met and HER2 receptor tyrosine kinase signaling
Mohamed R Akl, Nehad M Ayoub, Hassan Y Ebrahim, et al.
Oncotarget
|
August 22, 2015
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine
Mohamed R Akl, Poonam Nagpal, Nehad M Ayoub, et al.
Oncotarget
|
March 24, 2016
Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies
Mohamed R Akl, Poonam Nagpal, Nehad M Ayoub, et al.
Oncotarget
|
April 28, 2016
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
Arati A Inamdar, Andre Goy, Nehad M Ayoub, et al.
Oncotarget
|
February 9, 2017
Protein calorie malnutrition, nutritional intervention and personalized cancer care
Anju Gangadharan, Sung Eun Choi, Ahmed Hassan, et al.
International Journal of Occupational Medicine and Environmental Health
|
September 21, 2013
An audit on public awareness of depression symptoms in Jordan
Sayer Al-Azzam, Karem H Alzoubi, Nehad M Ayoub, et al.
International Journal of Breast Cancer
|
May 16, 2020
The Role of Establishing a Multidisciplinary Team for Idiopathic Granulomatous Mastitis in Improving Patient Outcomes and Spreading Awareness about Recent Disease Trends
Rami J Yaghan, Nehad M Ayoub, Shadi Hamouri, et al.
Oncotarget
|
November 20, 2020
Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine
Niraj Lodhi, Moe Tun, Poonam Nagpal, et al.
Oncotarget
|
August 27, 2016
Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine
Poonam Nagpal, Mohamed R Akl, Nehad M Ayoub, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Plos One
|
May 23, 2014
Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models
Mohamed R Akl, Nehad M Ayoub, Mohamed M Mohyeldin, et al.
Marine Drugs
|
January 13, 2015
Araguspongine C induces autophagic death in breast cancer cells through suppression of c-Met and HER2 receptor tyrosine kinase signaling
Mohamed R Akl, Nehad M Ayoub, Hassan Y Ebrahim, et al.
Oncotarget
|
August 22, 2015
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine
Mohamed R Akl, Poonam Nagpal, Nehad M Ayoub, et al.
Oncotarget
|
March 24, 2016
Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies
Mohamed R Akl, Poonam Nagpal, Nehad M Ayoub, et al.
Oncotarget
|
April 28, 2016
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
Arati A Inamdar, Andre Goy, Nehad M Ayoub, et al.
Oncotarget
|
February 9, 2017
Protein calorie malnutrition, nutritional intervention and personalized cancer care
Anju Gangadharan, Sung Eun Choi, Ahmed Hassan, et al.
International Journal of Occupational Medicine and Environmental Health
|
September 21, 2013
An audit on public awareness of depression symptoms in Jordan
Sayer Al-Azzam, Karem H Alzoubi, Nehad M Ayoub, et al.
International Journal of Breast Cancer
|
May 16, 2020
The Role of Establishing a Multidisciplinary Team for Idiopathic Granulomatous Mastitis in Improving Patient Outcomes and Spreading Awareness about Recent Disease Trends
Rami J Yaghan, Nehad M Ayoub, Shadi Hamouri, et al.
Oncotarget
|
November 20, 2020
Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine
Niraj Lodhi, Moe Tun, Poonam Nagpal, et al.
Oncotarget
|
August 27, 2016
Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine
Poonam Nagpal, Mohamed R Akl, Nehad M Ayoub, et al.
Page
of 7